Photo: Brooke Lark / Unsplash. Illustrative food image; not a prescribed meal or constipation treatment.
Evidence checked: October 9, 2026. Prepared with AI assistance and reviewed and approved for publication by David L. Carpenter, BSN, RN.
A change in bathroom habits can be an uncomfortable part of weight-management treatment. You may be eating smaller meals, adjusting to a new routine, and wondering whether harder stools are something to tolerate or something to report.
Constipation is listed among the common side effects of both Wegovy and Zepbound. That makes it a reasonable topic to bring up with your prescriber, not an embarrassing complaint you need to minimize. Common does not mean every episode is harmless. [1,2]
This guide is for adults using Wegovy or Zepbound injections. It explains how to describe the problem, when to seek help, and which everyday changes or treatment questions may be worth discussing. It does not provide a personalized laxative regimen or medication-dose plan.
Check for warning signs first
Get medical assessment right away if constipation occurs with constant abdominal pain, vomiting, inability to pass gas, fever, rectal bleeding, or blood in the stool. Severe or worsening pain, especially with vomiting, marked abdominal swelling, or inability to pass gas or stool, warrants emergency care because a bowel blockage is possible. Do not wait for every symptom to appear. [3,9]
If a blockage is possible, do not start or increase fiber supplements, laxatives, enemas, or other constipation remedies while delaying assessment. Sudden constipation with cramps and inability to pass gas or stool is specifically a reason to avoid laxatives and call for medical help immediately. [8,10]
Persistent severe abdominal pain, sometimes reaching the back, with or without nausea or vomiting, can signal pancreatitis. Both Medication Guides instruct patients with that pattern to stop using the medicine and contact their healthcare professional immediately. This is a specific emergency warning, not a suggestion to adjust routine doses yourself. [1,2]
Both guides warn that ongoing nausea, vomiting, or diarrhea can cause dehydration and kidney problems; contact your prescriber right away if these symptoms persist. Seek prompt assessment if you cannot keep fluids down or are urinating much less. Fainting, confusion, or no urination warrants emergency assessment. [1,2,11]
Describe more than how often you go
Constipation can involve fewer than three bowel movements a week, but frequency is only part of the picture. Hard or lumpy stools, difficult or painful passage, and feeling that you have not emptied completely also matter. Report a meaningful change from your usual pattern rather than relying on a single number. [3]
For example, “I went yesterday” leaves out whether passing stool required painful straining. “I have not gone as often” leaves out whether the stool remains comfortable to pass. Those details help your clinician understand the problem without requiring you to diagnose its cause.
A short description can start the conversation: when the change began, what passing stool feels like, and whether pain, vomiting, bleeding, or trouble passing gas is present. You do not need a perfect diary before asking for help.
What the medication evidence tells us
A published post-hoc analysis pooled three 68-week trials involving adults with overweight or obesity. During the on-treatment analysis, constipation rates adjusted for differences among the trials were 24.2% in the semaglutide 2.4 mg group and 11.1% in the placebo group. The pooled groups included 2,117 and 1,262 participants, respectively. One trial included people with type 2 diabetes; the other two did not. [4]
Novo Nordisk funded the trials and medical writing support for this paper; several authors were company employees. This was a post-hoc safety analysis. It combined trials with different populations and lifestyle interventions and relied on reported adverse events; it did not test constipation treatments. Its results do not predict your individual experience or estimate tirzepatide risk. Zepbound’s own Medication Guide identifies constipation as a common adverse effect. [2,4]
Avoid assuming that every bowel change has only one cause. Changes in food intake, fluids, activity, daily routine, other medicines, or an underlying condition can contribute. Iron supplements and some pain medicines, for example, can worsen constipation. Review the whole picture with your care team. [3]
Build food and fluid changes gradually
For mild symptoms without warning signs, general constipation guidance supports gradually adding suitable fiber-containing foods and drinking enough fluid. NIDDK lists foods such as oats and other whole grains, beans, lentils, fruits, and vegetables. Introduce fiber gradually so your digestive system can adjust. Fluid needs vary with health, activity, body size, and other circumstances. [5]
A practical starting question is whether your smaller meals still include any of those foods. If they have largely disappeared, ask a dietitian how to include a tolerable amount while meeting the rest of your nutrition needs. This does not require turning every meal into a large salad.
For example, you might discuss keeping a familiar fruit with breakfast or adding a small amount of lentils to a meal you already tolerate. Choose foods you tolerate; these examples are not a tested constipation treatment.
If your clinician has restricted fluids or given you a specific dietary plan, check before changing it. Do not force a universal water target or a large increase in fiber. If an attempted change makes symptoms worse, describe that response to your clinician rather than assuming you need to keep increasing it.
Give your bowel routine a little room
NIDDK says regular physical activity may help relieve constipation. Its guidance also encourages allowing time for a bowel movement rather than ignoring the urge. Trying the bathroom at a consistent time can help establish a routine; after breakfast is one suggested opportunity because eating stimulates colon activity. A footstool may make the position more comfortable. These are general constipation measures, not a proven GLP-1-specific program. [6]
Choose an opportunity that fits your life. For a shift worker, that may mean protecting a little time after the first meal of the waking day. A person with mobility limitations may need a different setup or assistance. The aim is a workable routine, not a requirement to produce a bowel movement on demand.
Activity should match your abilities and existing care plan. A brief comfortable walk may be a practical option for some people. It is not a reason to exercise through abdominal pain or postpone assessment of a concerning symptom.
Ask about remedies rather than stacking products
If everyday measures are not helping, ask your clinician or pharmacist what is appropriate. Laxatives and fiber supplements are not interchangeable, and the right choice depends on your symptoms, medical history, and other medicines.
The 2023 AGA–ACG guideline strongly recommends polyethylene glycol, or PEG, for adults with chronic idiopathic constipation. “Idiopathic” means there is no identified underlying cause. This guidance is useful background, but it is not direct evidence from trials treating constipation caused by Wegovy or Zepbound. [7]
The guideline conditionally supports fiber supplements; psyllium has the best evidence among the fibers evaluated, although certainty is low. Supplements require adequate fluid, and gas can occur. It also warns against magnesium oxide in people with impaired kidney function because magnesium can accumulate. A supplement being sold without a prescription does not make it suitable for everyone. [7]
PEG helps retain water in stool. MedlinePlus advises following directions and discussing possible bowel obstruction, medicines, and supplements with a healthcare professional before use. Bloating, cramps, or nausea can occur. [8] Follow the warning-sign guidance above: seek assessment for vomiting or significant abdominal pain rather than increasing laxative doses to work around those symptoms. [3,10]
Bring the actual product names or photographs of their labels to the discussion. Ask which product to use, how long to try it, what side effects to watch for, and when to call if it fails. A clear plan is more useful than adding a powder, gummy, tea, and tablet without knowing which ingredient is doing what.
Make the follow-up conversation useful
If symptoms persist, recur, or do not improve with self-care, arrange a clinical review. Review other medicines and possible underlying causes rather than repeatedly adding OTC products. Ongoing difficulty despite appropriate treatment may require pelvic-floor assessment or tests of bowel function. Your clinician decides which evaluation is appropriate. Do not change routine prescribed treatment on your own; the pancreatitis warning above is a separate safety instruction. [6,12]
Keep a brief note while arranging follow-up: the date of your last bowel movement, stool hardness, straining or incomplete emptying, associated symptoms, and anything you tried. Include when symptoms began relative to starting treatment or a prescribed dose change. Include other medicines and supplements, such as iron or opioid pain medicines. Keep the record brief. [3]
A message might read: “Since my recent treatment change, stools have become hard and difficult to pass. My last bowel movement was __. I have tried __. I do/do not have abdominal pain, vomiting, bleeding, or difficulty passing gas. What should I do next?” If warning signs are present, seek prompt care instead of relying on a routine portal message.
Constipation deserves attention even when weight loss is going well. The goal is comfortable bowel function and a treatment plan you can tolerate. Report the problem early, use routine measures thoughtfully, and get individualized help when those measures are not enough.
General educational information only; not individualized medical advice.
Sources
All sources accessed October 9, 2026. The Wegovy PDF includes injection and tablet labeling; this article addresses injections only.
1. Novo Nordisk. Wegovy Prescribing Information and Medication Guide. Revised June 2026. Medication Guide: possible side effects (PDF pages 19–20); injection scope.
https://www.novo-pi.com/wegovy.pdf
2. Eli Lilly. Zepbound Medication Guide. Revised August 2026. Possible side effects (PDF pages 2–3).
https://pi.lilly.com/us/zepbound-us-mg.pdf
3. NIDDK. Symptoms & Causes of Constipation. Last reviewed May 2018.
https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/symptoms-causes
4. Wharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24:94–105. DOI: 10.1111/dom.14551.
https://doi.org/10.1111/dom.14551
5. NIDDK. Eating, Diet, & Nutrition for Constipation.
https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/eating-diet-nutrition
6. NIDDK. Treatment for Constipation.
https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment
7. Chang L, et al. AGA–ACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164:1086–1106. DOI: 10.1053/j.gastro.2023.03.214.
https://doi.org/10.1053/j.gastro.2023.03.214
8. MedlinePlus. Polyethylene Glycol 3350. Drug information.
https://medlineplus.gov/druginfo/meds/a603032.html
9. MedlinePlus / NIDDK. Intestinal Obstruction.
https://medlineplus.gov/intestinalobstruction.html
10. MedlinePlus Medical Encyclopedia. Fecal impaction. Warning against laxatives with sudden constipation, cramps, and inability to pass gas or stool.
https://medlineplus.gov/ency/article/000230.htm
11. MedlinePlus. Dehydration. Warning signs and urgent assessment.
https://medlineplus.gov/dehydration.html
12. American Gastroenterological Association GI Patient Center. Constipation: Refractory. Secondary causes and testing.
https://patient.gastro.org/constipation-refractory/
Leave a Reply